Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) FCF Margin (2016 - 2026)

Usana Health Sciences has reported FCF Margin over the past 16 years, most recently at 2.84% for Q2 2026.

  • Quarterly FCF Margin fell 335.0% to 2.84% in Q2 2026 from the year-ago period, while the trailing twelve-month figure was 0.02% through Apr 2026, down 669.0% year-over-year, with the annual reading at 0.92% for FY2026, 621.0% down from the prior year.
  • FCF Margin was 2.84% for Q2 2026 at Usana Health Sciences, up from 2.73% in the prior quarter.
  • Over five years, FCF Margin peaked at 20.32% in Q4 2022 and troughed at 6.05% in Q3 2025.
  • The 5-year median for FCF Margin is 5.83% (2023), against an average of 6.03%.
  • Year-over-year, FCF Margin skyrocketed 1425bps in 2022 and then tumbled -2368bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 20.32% in 2022, then tumbled by -71bps to 5.84% in 2023, then plummeted by -53bps to 2.74% in 2024, then plummeted by -321bps to 6.05% in 2025, then soared by 147bps to 2.84% in 2026.
  • Per Business Quant, the three most recent readings for USNA's FCF Margin are 2.84% (Q2 2026), 2.73% (Q1 2026), and 6.05% (Q3 2025).